|CDC Investigates U.S. Multi-State Measles Outbreak|
The Centers for Disease Control and Prevention (CDC) issued an alert in late January on the multi-state outbreak of measles associated with travel to Disneyland Resort Theme Parks. The alert advised health care providers to ensure that all of their patients are current on MMR (measles, mumps, and rubella) vaccine and to consider measles in the differential diagnosis of patients with fever and rash. In addition, providers should ask patients about recent international travel or travel to domestic venues frequented by international travelers and about their history of measles exposures in their community. |
IDSA offers two email services to help members stay informed of new drug approvals and similar updates from the Food and Drug Administration and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. Recent alerts have included:
Approval changes to the Kaletra (lopinavir/ritonavir) Label (dosing recommendations for pregnant women) 1/28/15
FDA approves a second vaccine to prevent serogroup B meningococcal disease 1/23/15
FDA warns health care professionals not to inject patients with IV solutions from Wallcur, of San Diego 1/14/15
FDA approves new antibacterial drug Zerbaxa 12/19/14
IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network [HAN] messages and/or alerts from FDA, and provide your email address and name where indicated.)
Is Your Facility Experiencing Antibiotic Shortages?
IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at email@example.com.
< Previous Article | Next Article >